|
|
Next generation interbody fusion device. Rhakoss implants represent the first synthetic bioactive, bone-bonding alternative to titanium/carbon fiber cages and allograft cadaver bone implants. RHAKOSS combines the best features of first generation IBFDs while eliminating many of the disadvantages of current available materials, such as inconsistent structural integrity, ineffective radiolucency, lack of bony interdigitation, risk of disease transmission, limited supply, etc.
|